Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Moreno

Showing results (391-400 of 403) with videos related to

Pageof 41
Sort By:
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
Statistical Methods in Medical Research|July 27, 2018
Compositional analysis of dietary patternsM Solans, G Coenders, R Marcos-Gragera, et al.
Systematic Reviews|June 2, 2024
Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviewsE Plans-Beriso, C Babb-de-Villiers, D Petrova, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Bone Marrow Transplantation|November 25, 2023
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP studyA Mussetti, B Rius-Sansalvador, V Moreno, et al.
The Pharmacogenomics Journal|February 8, 2012
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administrationC Fernandez-Rozadilla, J B Cazier, V Moreno, et al.
British Journal of Cancer|November 11, 2010
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsE Theodoratou, H Campbell, A Tenesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2024
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancerR S Laskar, C Qu, J R Huyghe, et al.
British Journal of Cancer|November 19, 2009
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancerI P M Tomlinson, M Dunlop, H Campbell, et al.
Pageof 41

Showing results (391-400 of 403) with videos related to

Sort By:
Pageof 41
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
Statistical Methods in Medical Research|July 27, 2018
Compositional analysis of dietary patternsM Solans, G Coenders, R Marcos-Gragera, et al.
Systematic Reviews|June 2, 2024
Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviewsE Plans-Beriso, C Babb-de-Villiers, D Petrova, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Bone Marrow Transplantation|November 25, 2023
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP studyA Mussetti, B Rius-Sansalvador, V Moreno, et al.
The Pharmacogenomics Journal|February 8, 2012
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administrationC Fernandez-Rozadilla, J B Cazier, V Moreno, et al.
British Journal of Cancer|November 11, 2010
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsE Theodoratou, H Campbell, A Tenesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2024
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancerR S Laskar, C Qu, J R Huyghe, et al.
British Journal of Cancer|November 19, 2009
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancerI P M Tomlinson, M Dunlop, H Campbell, et al.
Pageof 41